Content
What is SPRAVATO?
SPRAVATO® is a prescription esketamine nasal spray for adults with treatment-resistant depression. For this condition, it may be used alone or with an oral antidepressant. A clinician reviews your history, risks and other options before recommending treatment.
Plan for a monitored visit
SPRAVATO is taken under healthcare-provider supervision in a REMS-certified setting. Monitoring continues for at least two hours after dosing; the clinician determines when you are ready to leave. This is not the total appointment length. Arrange a ride home. Do not drive or operate machinery until the next day after restful sleep.
Important safety information
SPRAVATO can cause serious sleepiness, feeling disconnected from yourself or your surroundings, breathing problems and increased blood pressure. It also carries abuse and misuse risks. Antidepressants can increase suicidal thoughts or actions in some younger people; promptly report new or worsening symptoms. Discuss your medical conditions, medicines, pregnancy or breastfeeding with your clinician and read the full Medication Guide. This is not a complete list of risks.
Available in Milford and Southport
Mood Institute offers SPRAVATO at both offices. Use Request Consultation to ask about an evaluation and next steps. Our administrative and clinical teams reply within one business day. A request is not a confirmed appointment or a treatment recommendation.
Insurance and costs
Coverage, authorization requirements and out-of-pocket costs vary by service and plan. Ask our administrative team about practice questions and confirm benefits for the proposed service with your insurer.